Key Publications February 21, 2017

Semaglutide and cardiovascular outcomes in patients with type 2 diabetes.

N Engl J Med. 2016;375:1834-1844

Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML, Woo V, Hansen O, Holst AG, Pettersson J, Vilsbøll T, SUSTAIN-6 Investigators